The present invention discloses an anticancer pharmaceutical composition, comprising the following materials in parts by weight: 0.5-30 parts of fruits/leaves of Rosa roxburghii, 0.5-30 parts of fruits/leaves of Phyllanthus emblica, 0.5-30 parts of peel/seeds of Punica granatum, 0.5-30 parts of honey, 0.5-30 parts of flesh/pericarp of Garcinia mangostana, 0.5-30 parts of coconuts, 0.5-30 parts of pulp/peel of Citrus limon, 0.5-30 parts of raw walnuts, 0.1-5 parts of Rhizoma gastrodiae, 0.1-5 parts of Lucid ganoderma, 0.1-5 parts of seeds/leaves of Moringa oleifera, 0.01-2 parts of Radix ranunculi ternati and 0.01-2 parts of Rhizoma paridis.
